Montreal, Canada

Curtis Colwell

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Curtis Colwell. Retrieved from https://idiyas.com/inventor/curtis-colwell-pagrm3jl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Curtis Colwell: Innovator in Pyrazolo Compounds

Introduction

Curtis Colwell is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have the potential to treat serious diseases.

Latest Patents

Colwell holds a patent for "Pyrazolo compounds and methods of use thereof." This patent relates to compounds and methods for using these compounds, as well as pharmaceutical compositions that contain them, aimed at treating diseases and conditions mediated by TEAD, such as cancer. He has 1 patent to his name.

Career Highlights

Colwell is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work focuses on creating effective treatments that can significantly impact patient outcomes.

Collaborations

Throughout his career, Colwell has collaborated with talented individuals such as Jason R Zbieg and Russell Tyler Smith. These partnerships have fostered an environment of innovation and creativity in the research and development of new therapeutic solutions.

Conclusion

Curtis Colwell's work in the field of pyrazolo compounds exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for advancements in cancer treatment and improving the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…